Remove 2030 Remove Communication Remove Compounding
article thumbnail

Veterinary Medicine Outlook: 5 Changes and Trends Impacting Veterinary Practices

epicur

Implementation of GFI #256 Earlier this year, the FDA finalized regulatory guidance for compounded medications, known as GFI #256. If GFI is affecting your practice’s ability to get compounded medications for office use, partnering with a trusted 503B outsourcing facility can help you eliminate risks of limited ordering.

article thumbnail

Healthier Together and philanthropic ventures in tropical disease

European Pharmaceutical Review

The Kigali Summit on Malaria and NTDs , hosted by His Excellency (HE) Paul Kagame, President of the Republic of Rwanda, on Thursday 23 June 2022, gathered world leaders to commit to ending these devastating diseases by the end of 2030. Europe’s Healthier Together initiative. A guidance document has been released to support these activities.

Vaccines 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Too Much of a Good Thing? Unpacking the Rise of Polypharmacy in Seniors

PharmD Live

Their projections indicate that approximately 10,000 people will turn 65 each day over the next 19 years, with the population of older adults expected to double to 80 million by 2030. At this rate, nearly half of the older population could be impacted by polypharmacy by 2030. Data from the U.S. in 1994 to 42.4%

article thumbnail

PharmaShots' Key Highlights of First Quarter 2023

PharmaShots

It now offers DPN patients relief from chronic pain through low doses of stimulation & the battery lasts up to 10 years at low-dose settings The system also pairs with Abbott’s NeuroSphere Virtual Clinic, a connected care app for people to communicate with a physician and receive remote treatment adjustments.

article thumbnail

Readmission on the Horizon: How EU funding can boost British biotech

Pharmaceutical Technology

The possibility of additional funding comes at a time replete with investor uncertainty as a result of ongoing financial instability in the market, which has been compounded by the collapse of Silicon Valley Bank (SVB) and Credit Suisse. billion) by 2030. The UK government also has its own plans for funding research. billion ($18.2

Vaccines 111